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Abstract
Objective—Velo-cardio-facial syndrome (VCFS; 22q11.2 deletion syndrome) represents one of
the highest known risk factors for schizophrenia. Insofar as up to thirty percent of individuals with
this genetic disorder develop schizophrenia, VCFS constitutes a unique, etiologically
homogeneous model for understanding the pathogenesis of schizophrenia.
Method—Using a longitudinal, case-control design, we acquired anatomic magnetic resonance
images to investigate both cross-sectional and longitudinal alterations in surface cortical
morphology in a cohort of adolescents with VCFS and age-matched typical controls. All
participants were scanned at two time points.
Results—Relative to controls, youth with VCFS exhibited alterations in inferior frontal, dorsal
frontal, occipital, and cerebellar brain regions at both time points. We observed little change over
time in surface morphology of either study group. However, within the VCFS group only,
worsening psychosocial functioning over time was associated with Time 2 surface contractions in
left middle and inferior temporal gyri. Further, prodromal symptoms at Time 2 were associated
with surface contractions in left and right orbitofrontal, temporal and cerebellar regions, as well as
surface protrusions of supramarginal gyrus.
Conclusions—These findings advance our understanding of cortical disturbances in VCFS that
produce vulnerability for psychosis in this high risk population.
Keywords
velo-cardio-facial syndrome; 22q11.2 deletion syndrome; schizophrenia; prodromal; cortical
morphology
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INTRODUCTION
Despite our improved understanding of the neuroanatomic correlates of schizophrenia, we
still have not definitively identified the longitudinal trajectory of abnormalities in brain
structure during adolescence that constitute vulnerability to psychosis. Recent longitudinal
studies of adolescents at clinical or familial high risk for schizophrenia 1–3 suggest that
youth displaying prodromal or psychotic symptoms show age-related gray matter loss in
superior, and inferior temporal lobe, superior and inferior 1, 2 frontal lobe, and cingulate.
However, the etiological heterogeneity of schizophrenia continues to challenge these efforts.
This challenge can be addressed, in part, by identifying neurobiological abnormalities in
specific genetic syndromes that place individuals at an increased non-familial risk for
schizophrenia. One such disorder is velo-cardio-facial syndrome (VCFS; 22q11.2 deletion
syndrome). This syndrome confers the highest known risk for developing schizophrenia,
with up to 25% of individuals developing schizophrenia in adulthood. VCFS therefore
provides a unique, etiologically homogeneous model for understanding the neurobiological
underpinnings of at least one form of schizophrenia. Here we report findings from a
longitudinal study of cortical morphology and psychiatric functioning in a cohort of 44
youth with VCFS. Most cross-sectional investigations of brain morphology in VCFS have
been limited to traditional volumetric analyses 3–6 7–11. More recently, studies have
reported cortical thinning in parietal-occipital regions and inferior frontal gyrus 12 and
reduced gyrification in the frontal, temporal, and parietal lobes 13 of individuals with VCFS.
One longitudinal study of brain development 14, 15 reported that VCFS-affected youth
exhibited increased volumes of cranial and cerebellar white matter, increased caudate
nucleus volumes, and reduced amygdala volumes. A recently published study of age-related
changes in cortical thickness 16 reported cortical thinning in frontal, parietal, and occipital
cortices over a three-year period in adolescents with VCFS. The current report complements
these studies by examining longitudinal alterations (ie., surface contractions or protrusions)
in cortical morphology and associations with psychatric symptoms. This knowledge
contributes to the growing literature documenting specific anatomical abnormalities that
produce cognitive and emotional disturbances in youth with VCFS 7, 9, 17, 18 and place
them at elevated risk for psychosis as they reach adulthood.
Based on extant studies of individuals with VCFS and those with idiopathic schizophrenia,
we hypothesized that relative to controls, youth with VCFS would exhibit (1) cross-sectional
contractions in posterior cortical surfaces (e.g. parietal, temporal and occipital lobes, and the
cerebellum) and protrusions in frontal cortical surfaces 3, 4, 6 ; and (2) more robust
contractions of frontal, parietal and occipital cortices 16 over time. We further predicted that
(3) contractions of frontal and temporal lobes 19, 20 at both Time 1 and Time 2 in youth
with VCFS would be associated with more prodromal symptoms at Time 2.
METHOD
Sample
The sample (Table 1), drawn from a larger, longitudinal study of biomarkers for psychosis
in VCFS9, 10, 21–28, consisted of 44 children with VCFS, 13 siblings of VCFS children,
and 12 community controls. The sibling sample did not differ from the community sample in
age (p = .92), gender distribution (p = .99) or full scale IQ (p = .15). Moreover, VCFS is a de
novo dominant mutation that cannot confer carrier status on a sibling. Accordingly the two
groups were combined into one control sample.
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All participants were from 9 to 15 years of age at baseline. Families of children with
cytogenetically-confirmed VCFS were recruited primarily from a VCFS Center at an urban
medical center. Community controls were recruited through fliers distributed to local
schools. Exclusion criteria for controls included seizure disorder, fetal exposure to alcohol
or drugs, elevated lead levels, birthweight under 2500 grams (as reported by parents),
paramagnetic implants, or orthodontic braces, and a previous diagnosis or family history of
either schizophrenia or bipolar disorder. We did not screen, however, for the presence
ADHD. Given the high incidence of ADHD in youth with VCFS, we did not screen for
ADHD in controls, reasoning that controls with possible ADHD would provide a reasonable
match to the higher-functioning VCFS participants, as well as control for potential
alterations in cortical morphology that may be associated with ADHD 29. All participants
and their parents provided informed assent or consent based on guidelines of our
Institutional Review Board.
Participants were originally recruited and scanned at baseline (Time 1) between 2002 and
2005. Seventy-nine percent of participants recruited at Time 1 returned approximately three
years later for follow-up (Time 2). Participants who did not return for follow-up did not
differ significantly from returnees by age (F = 1.57; p = 0.21), IQ (F = 0.5; p = 0.48) or SES
(F = 0.00; p = 0.99). The sample described here consists only of those participants for whom
we have assessments at both Time 1 and Time 2.
MRI Acquisition and Processing
MRIs were acquired in the axial plane on a 1.5 T Philips Gyroscan scanner (Philips Medical
Systems, Best, The Netherlands) utilizing the following T-1 weighted inversion recovery,
turbo gradient echo (TFE) 3-D pulse sequence: echo time = 4.6; repetition time = 20; 2
repetitions; matrix size 256 × 154; field of view = 24 cm; multishot = 32; TFE pre-inversion
recovery = 394 ms, 1.5 mm slice thickness.
Imaging data were transferred to local workstations via network connections. After isolating
brain from nonbrain tissue using automated procedures30 images were transferred via FTP
to Columbia University, where morphology of the brain surfaces (defined by all pixels in the
interface of gray matter and CSF across the entire brain) was assessed. This procedure,
summarized below, employed previously validated and automated algorithms. 31–33 First,
brains at Time 2 were coregistered to an appropriately selected template brain at Time 2 32
using a similarity transformation, followed by a high-dimensional, nonrigid warping
algorithm using the principles of fluid dynamics 34. Each brain was warped to the exact
same size and shape as the template brain, thereby identifying corresponding points across
the surface of each brain and the template brain. Second, each participant’s brain at Time 1
was coregistered and warped to the same participant’s brain at Time 2 to identify
corresponding points on the brain surfaces at Times 1 and 2. We then applied the warping
from the first step to the participant’s brain at Time 1, determining precisely the
corresponding points on the template surface and brain surface for each subject at Time 1.
Approximately 85,000 points were identified on the surface of the template brain. Because
each participant’s brain at Time 1 well-matches that participant’s brain at Time 2,
coregistering and warping each Time 1 brain to its Time 2 counterpart minimizes errors in
determining correspondences across the two surfaces. Our two-step procedure therefore
precisely determines the correspondences between points on the template surface and those
on the brain surfaces at Time 1. We then computed signed Euclidean distances between
corresponding points across the cerebral surfaces for each participant from the template
surface.
The signed Euclidean distances that we computed at each point at the cortical surface were
statistically analyzed using multiple linear regression. We computed these test statistics for
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the comparison of cortical morphology between study groups, and across time within study
groups, while covarying for age and sex, having first ensured the absence of quadratic and
cubic effects of age, and significant interactions among group, age, and sex. (On the basis of
permutation analyses that tested the magnitude of association in Euclidean distances
between VCFS subjects and both sibling and non-sibling controls, we determined that
familial relatedness did not influence our results and, therefore, did not control for that
factor.) We corrected for the multiple statistical comparisons performed at each point across
the cerebral surface using the theory of Gaussian Random Fields (GRF). Type 1 error caused
by multiple hypothesis testing could be minimized by applying the Bonferroni correction if
the data on the neighboring voxels were statistically independent. However, the imaging
data on the neighboring voxels are correlated and therefore Bonferroni correction is very
conservative. To appropriately minimize the Type 1 error, we modeled the correlated
imaging data across the brain surface as a Gaussian random field, and applied the theory of
Guassian Random Fields on a 2-dimensional manifold 35 to compute p-values of
significance that were corrected for these multiple comparisons.35 Thus, our GRF-corrected
images display surface points that withstood a stringent statistical threshold for multiple
comparisons. These methods have excellent sensitivity and specificity for detecting
morphological abnormalities at the cortical surface31.
Assessment of Cognitive and Psychiatric Functioning
All participants, including children with VCFS and controls, were administered identical
batteries assessing cognitive and psychiatric functioning.
The Wechsler Intelligence Scale for Children-Third Edition (WISC-III) was administered to
all participants at Time 1. At Time 2, either the WISC-III or the Wechsler Adult Intelligence
Scale-Third Edition was administered, depending on the age of the participant. Comparative
studies between the Wechsler child and adult intelligence scales suggest that relative to
WISC-III scores, WAIS-III scores are inflated between three and seven points. 36–38
Accordingly we subtracted five points from WAIS-III full-scale IQ scores.
The Schedule for Affective Disorders and Schizophrenia for School-Age Children—Present
and Lifetime Version (K-SADS-PL) was administered by a child psychiatrist or
psychologist (mean kappa inter-rater reliability across all diagnoses, .91) to the child and
primary caregiver to assess the presence of child psychiatric diagnoses at both timepoints
(Table 2). In the cases in which children had difficulty responding to interview questions
due to cognitive deficits, final scores were based on the parent interview. 22, 27
We correlated the measures of psychiatric functioning described below with cortical
morphology.
The Children’s Global Assessment Scale (CGAS) 39 assesses global functioning. The
CGAS was scored at Times 1 and 2 by doctoral-level clinicians within the context of
administering the K-SADS-PL. We correlated Time 2 CGAS scores with cortical
morphology at Times 1 and 2, and CGAS change scores (Time 2 minus Time 1) with
cortical morphology at Time 2.
The Scale of Prodromal Symptoms (SOPS)40 was administered by a doctoral – level
clinician during the structured psychiatric interview at Time 2 only. Inter-rater reliability,
based on five SOPS interviews and assessed with the intraclass correlation coefficient, was
0.90. The SOPS consists of four domains, in which the clinician rates each participant and
derives summary scores for positive prodromal symptoms, negative prodromal symptoms,
disorganization, and general symptoms. As reported previously 27 we calculated a total
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SOPS summary score from the Positive, Negative and Disorganization subscales of the
SOPS (excluding the General subscale due to non-specificity).
Correlational Analyses
For the VCFS group only, multiple linear regression analyses were used to analyze the
association between cortical surface morphology at Times 1 and 2 and scores on the Time 2
CGAS as well as CGAS change scores (Time 2 minus Time 1). Scores for the CGAS were
regressed on the signed Euclidean distances that had been computed between corresponding
points across the cerebral surfaces of each participant and the template surface. Associations
between Time 1 and Time 2 Euclidean distances and Time 2 SOPS scores were assessed
with the Zero-inflated Poisson regression analyses 41 due to the distribution of our SOPS
data, which was a count of symptoms for which at least 50% of scores equaled zero
(indicating the absence of any prodromal symptoms). 27 We covaried for age and sex in all
regression analyses. Since FSIQ was correlated with CGAS scores, we also covaried for
FSIQ in our CGAS analyses. All analyses were GRF-corrected for multiple comparisons.
Due to restricted distribution of psychiatric function scores in the control group, analyses
were conducted for the VCFS group only.
RESULTS
Group Differences at Time 1 and at Time 2
Figure 1 depicts differences in cortical surface morphology between study groups at Time 1
and Time 2. GRF-corrected analyses indicated that at both Time 1 and Time 2, youth with
VCFS relative to controls exhibited significant reductions (ie., contractions of the cortical
surface) bilaterally in inferior frontal cortex (BA 44, 45, and 47), anterolateral orbitofrontal
cortex (OFC) (BA 11), inferior postcentral gyrus (BA 3), primary visual cortex (BA 17),
inferior temporal gyrus (BA 20), and anterior cerebellum. In addition, youth with VCFS
exhibited bilateral increases (ie., protrusions of the cortical surface) in the dorsal frontal
cortices (BA 6, 8, and 9). The similarity of the maps at Times 1 and 2 demonstrates the
remarkable test-retest reliability of these measures. In addition, Figure S1, available online,
provides information on the effect sizes and variance of our findings, further supporting
their validity.
Because IQ scores differed significantly between study groups, we conducted the same
analyses as above, but entered IQ as a main effect and study group by IQ as an interaction
term. Our findings indicated that the effect of IQ on cortical morphology did not differ
appreciably between study groups (see Figure S2, available online).
Within-Group Changes from Time 1 to Time 2
We observed relatively little change in cortical morphology over the three-year period for
either youth with VCFS or controls. Uncorrected images indicated that both typical youth
and those with VCFS experienced local reductions in the anterior aspect of left middle and
inferior frontal gyri (BA 9, 45, 46, 47), left middle temporal gyrus (BA 21), and bilateral
cerebellum. VCFS youth also exhibited reductions in inferior parietal lobule (BA 40) and
inferior occipital gyrus (BA 19) (not shown). However, reductions in most of those areas did
not survive GRF correction. In addition, regression models in which we subtracted Time 1
distances from Time 2 distances, and then regressed age, sex and diagnostic status (VCFS
vs. controls) onto the resulting net distances, did not yield significant results, indicating that
age-related changes did not differ by study group.
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Correlations of Cortical Morphology with Functional Impairment and Prodromal Symptoms
At our Time 2 assessment, 25% of our VCFS sample were experiencing intermittent
symptoms of psychosis (primarily hallucinations) as assessed with the K-SADS-PL
compared with 4% of our control sample (Table 2). Youth with VCFS who demonstrated
transient, intermittent symptoms of psychosis showed significantly greater impairment than
non-symptomatic (for psychosis) youth on both the CGAS (F (1,42) = 8.5; p < .006) and the
SOPS (F (1,42) = 35.6; p < 0.0001). The images in Figure 2 depict associations between
Time 1 and Time 2 cortical morphology, and Time 2 scores on the CGAS and the SOPS in
the VCFS group. Figure 3 depicts scatterplots and graphs representing these associations.
Figure 4 depicts a scatterplot representing the association between CGAS change scores and
Time 2 cortical morphology. After GRF correction, we observed that at both Time 1 and
Time 2, greater reductions in left superior and middle temporal gyri was significantly
associated with greater functional impairment on the Time 2 CGAS, as were small
reductions in left postcentral and precentral gyrus. Moreover, worsening CGAS scores over
time were significantly associated with cortical contractions in left middle and inferior
temporal gyri at Time 2. At both Time 1 and Time 2, cortical contractions in left and right
(data not shown for right hemisphere) lateral orbitofrontal cortex, superior (to a small
extent) and inferior temporal gyri, and cerebellum, and cortical protrusions in supramarginal
gyrus were associated with higher Time 2 SOPS scores. Contractions in inferior frontal
gyrus at Time 2 only were also associated with Time 2 prodromal symptoms. Interestingly,
widespread contractions of left and right superior and middle temporal gyri at Time 1, but
not at Time 2, were also associated with more prodromal symptoms at Time 2.
DISCUSSION
In sum, we observed that in cross-sectional analyses, at both Time 1 and Time 2, youth with
VCFS relative to controls exhibited morphological alterations in inferior frontal, dorsal
frontal, occipital, and cerebellar brain regions. Longitudinal analyses revealed little change
in cortical morphology over time in either youth with VCFS or controls. However, we
observed that Time 1 and Time 2 contractions in left and right orbitolateral frontal and
inferior temporal gyri, and protrusions in parietal cortex, were robustly associated with more
prodromal symptoms in the VCFS group at Time 2. In addition, Time 1 and Time 2
contractions over the left superior and middle temporal gyri were associated with lower
CGAS scores in the VCFS group at Time 2.
Between-Group Comparisons at Each Time Point
At both Time 1 and Time 2 we detected in VCFS youth increases in dorsal and ventromedial
prefrontal cortices, and contractions of Broca’s region, ventrolateral prefrontal cortex,
occipital cortex, and anterior cerebellum, Our findings of frontal enlargement are consistent
with prior studies reporting increased overall frontal volumes relative to whole brain
volumes in youth with VCFS, although reduced volumes have also been reported in specific
frontal subregions. 25, 42. The superior frontal gyrus has been associated with motor
planning, a capacity that is often impaired in children with VCFS 43. Contractions detected
in more inferior prefrontal regions, in contrast, may underlie reported deficits in response
inhibition in youth with VCFS 44.Whereas previous studies using ROI-based measures have
reported significant decreases in volume of the cerebellum in VCFS, volume reductions in
Broca’s region have not been reported previously. Contractions in Broca’s region (BA 44
and 45) and the anterior cerebellum could underlie the well-documented language deficits in
VCFS 45. Primate studies demonstrate projections from superior cerebellum to inferior
frontal cortex 46 supporting functional imaging findings of co-activation of cerebellum and
inferior prefrontal cortex in language processing 47 and word generation 48. These findings
suggest alterations in brain regions that compose cortico-cerebellar circuits in children with
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VCFS. This circuit contains feed-forward46 and feed-backward 49, 50 pathways that link
the cerebellum to the cerebral cortex. Primate studies 49 and human functional imaging
studies suggest that cortico-cerebellar circuits support several cognitive functions, including
executive functioning51, working memory47, temporal discrimination38, and language
processes 52. Thus each of the cognitive functions attributed to the corticocerebellar
pathway is known to be impaired in persons with VCFS53–59. We detected morphological
abnormalities in each of the regions composing this circuit in children with VCFS.
Changes in Cortical Surface Over Time
Between Time 1 and Time 2, cortical surface morphology in both study groups was
relatively consistent, suggesting little change in the overall contours of the cortical surface
over a three-year period. Although several studies of age-related changes in gray matter
density in typically developing youth 60, 61 have been published, relatively few studies
have focused on changes in cortical surface morphology between childhood and
adolescence. The method for mapping cortical surface morphology that is comparable to our
method is the “distance from center” (DFC) method, included within the rubric of cortical
pattern matching techniques developed at UCLA (see review by 62). Applying the DFC
method to a cross-sectional sample of cortical morphology in youth and young adults, 63
few differences were observed between surface morphology of children and adolescents
(comparable in age to our sample). In contrast, significant differences were observed in
cortical surface (particularly dorsal frontal cortex and temporal cortex) between adolescents
and adults. Based on these prior findings, we anticipate observing more robust changes in
the cortical surface, at least in our control sample, when they are imaged at future time
points.
Associations with Prodromal Symptoms and Psychosocial Functioning
We observed that a greater burden of prodromal / functional symptoms in the VCFS group
at Time 2, and worsening in psychosocial functioning over time, were associated with
cortical surface contractions in inferior frontal lobe, temporal lobe and cerebellum, and
cortical protrusions in parietal cortex. Findings of frontal and temporal lobe contractions are
consistent with longitudinal studies of adolescents at ultra high risk for schizophrenia that
have reported neurodevelopmental abnormalities in superior temporal and frontal cortices
during adolescence that predate the onset of overt psychosis 19, 20, 64. Parietal anomalies
have also been reported in youth at genetic risk for schizophrenia 65 as well as those with
psychosis 66. Although most studies have observed parietal reductions associated with
psychosis, volumetric increases in parietal cortex 67 have also been reported. The presence
of an association between Time 1, but not Time 2, superior temporal contractions and Time
2 prodromal symptoms may be a function of the developmental trajectory of superior
temporal gyrus. Whereas frontal and parietal gray matter peak in early adolescence,
temporal gray matter peaks between 14 and 16 years of age 68, 69, which coincides with the
mean age of our participants at Time 2. At Time 1, therefore, superior temporal lobe
contractions may have been specific to those youth who later developed prodromal
symptoms. By Time 2, however, subtle cortical contractions in the superior temporal lobes
of non-prodromal youth may have reduced the specificity of this association.
The results of this study must be viewed in the context of several limitations. Correlations of
our psychosocial measures with cortical morphology were limited in their clinical relevance,
because our sample has not yet reached the age of greatest risk for onset of psychosis.
In addition, the choice of appropriate comparison samples in studies of youth with
genetically based impairments in cognitive and emotional functioning is controversial.
Recruiting a sample of controls with idiopathic intellectual impairments can produce an
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etiologically heterogeneous sample, potentially undermining the validity of data
interpretation. The inclusion of a sample of typically developing controls, however, can
contribute to findings that derive from nonspecific differences in intellectual capacities,
rather than from the predisposition to develop psychotic illness per se.
Finally, as noted in Table 2, many of the youth in our sample are prescribed medications for
current psychiatric disorders. Although we could not identify published studies that
documented an effect of medication on cortical patterning, the potential effect of medication
usage cannot be ruled out since our sample size was not large enough to control for
medication usage.
Despite these limitations, our findings advance substantially the understanding of both the
neural bases of VCFS and the alterations in brain development that contribute to functional
psychiatric impairment in adolescents with VCFS. Moreover, because VCFS represents the
highest known risk factor for schizophrenia apart from having an identical twin or two
parents with this devastating psychiatric disorder, these findings contribute significantly to
our understanding of anomalies in cortical surface morphology that may underlie the
vulnerability to psychosis in non-VCFS adolescents who are at risk for schizophrenia.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Group differences in morphological features of the cortical surface
Results are displayed for left lateral, right lateral, anterior, inferior and posterior views of the
cortical surface at Time 1 and Time 2. The figure is based on a statistical model that
includes study group (Velo-cardio-facial syndrome [VCFS] vs. control) as the main effect
while covarying for age and sex. The color bar provides the color-coding for the main
effects of study group. Warmer colors (red and yellow) indicate protruding surface
(presumably representing larger underlying volumes) in youth with VCFS relative to
controls, and the cooler colors (blue and purple) indicate indented, contracted surfaces
(presumably representing smaller underlying volumes) in youth with VCFS relative to
controls.
Maps display images both corrected and uncorrected for multiple comparisons using
Gaussian Random Fields (GRF). The GRF-corrected images depict voxels surviving
rigorous correction for multiple comparisons. Because the corrections are so rigorous,
however, they may not fully represent the underlying spatial or anatomical configuration of
the statistical effects we are modeling (as the anatomical location of the voxels identified in
this sort of map are vulnerable to the effects of statistical thresholding that can cause them to
shift in location). From the standpoint of accurately identifying anatomical subregions that
carry the effect being modeled, GRF-uncorrected images are preferred; but from the
standpoint of identifying voxels involved in the effect with the greatest statistical certainty,
GRF-corrected images are preferred. Thus, GRF-corrected and –uncorrected images
Kates et al. Page 12
J Am Acad Child Adolesc Psychiatry. Author manuscript; available in PMC 2012 March 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
together provide complementary information about the effect being modeled, each of which
is important to the aims of the study.
The second row of the Time 1 images displays an overlay of cytoarchitectonic –based
regions. Overlaid letters correspond to the following regions of interest: A: superior frontal
gyrus; B: middle frontal gyrus; C: inferior frontal gyrus; D: lateral orbital frontal gyrus; E:
precentral gyrus; F: postcentral gyrus; g: superior temporal gyrus; H: cerebellum; I: cuneus;
J: superior occipital gyrus; K: inferior occipital gyrus. With kind permission of Paul M.
Thompson, Laboratory of NeuroImaging, University of California at Los Angeles
http://www.loni.ucla.edu/ICBM/Downloads/Downloads_ICBMtemplate.shtml.
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Figure 2. Correlations between cortical morphology and psychiatric function in the VCFS cohort
Images depict the association between cortical morphology at Time 1 and Time 2 and Time
2 scores on the Children’s Global Assessment Scale (CGAS) and Scale of Prodromal
Symptoms (SOPS). Warmer colors depict positive associations between psychiatric function
scores and cortical morphology, and cooler colors depict negative associations between
scores and cortical morphology. Higher scores on the the SOPS indicate poorer psychiatric
function, whereas lower scores on the CGAS indicate poorer psychiatric function.
Accordingly, the negative associations noted for the SOPS indicated that cortical
contractions were associated with poorer functioning on that scale. Similarly, the positive
association noted for the CGAS indicated that cortical contractions were also associated
with poorer functioning. Regions in which associations were noted included: A: middle
frontal gyrus; B: inferior frontal gyrus; C: lateral orbitofrontal gyrus; D: precentral gyrus; E:
postcentral gyrus; F: superior parietal lobule; G: supramarginal gyrus; H: inferior parietal
lobule; I: superior temporal gyrus; J: middle temporal gyrus; K:inferior temporal gyrus; L:
cerebellum.
Kates et al. Page 14
J Am Acad Child Adolesc Psychiatry. Author manuscript; available in PMC 2012 March 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 3. Box and scatterplots depicting associations between cortical distances and psychiatric
function
This figure consists of box plots and scatterplots depicting the association between Time 2
cortical distances (in millimeters) and the Time 2 Scale of Prodromal Symptoms (SOPS) and
Children’s Global Assessment Scale (CGAS) scores, respectively. Each arrow locates the
specific point for which its corresponding plot was generated. Points which reflected highly
significant results were chosen for visualization with plots. The statistical association
between distances and SOPS scores was calculated with the zero-inflated Poisson
regression, which generates z-scores, provided in the upper left corner of each SOPS plot.
The error bars in the box plots depict one standard deviation. Statistical associations
between distances and CGAS scores were calculated with linear regressions: coefficients are
provided in the lower right corner of each of those plots.
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Figure 4. Scatterplots depicting associations between cortical distances and Children’s Global
Assessment Scale (CGAS) change scores
This figure consists of a scatterplot depicting the association between Time 2 cortical
distances (in millimeters) and CGAS change (Time 2 minus Time 1) scores. The arrow
locates the specific point for which the plot was generated. The statistical association
between cortical distances and CGAS change scores was calculated with a linear regression:
the coefficient is provided in the lower right corner of the plot. As in Figure 2, warmer
colors depict positive associations between CGAS change scores and cortical morphology,
such that cortical contractions were associated with negative change scores (indicating a
worsening of psychosocial functioning).
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Table 1
Participant Characteristics
VCFS
(N=44)
Controls
(N=25)
ANOVA
F-value (d.f.)
P-value
Mean (S.D.) Mean (S.D.)
Age at Time 1 11.9 (2.2) 11.4 (1.9) .82 (1, 67) .37
Age at Time 2 15.1 (2.1) 14.5 (1.8) 1.3 (1, 67) .31
Sex 25 F, 19 M 13 F, 12 M .74
Years between Time 1 and Time 2 3.2 (.39) 3.2 (.51) .11 (1, 67) .19
Full Scale IQ / Time 1 72.7 (12.2) 98.8 (16.2) 57.9 (1, 67) .0001
Full Scale IQ / Time 2 71.5 (12.6) 97.8 (14.5) 62.3 (1, 67) .0001
CGAS Score / Time 1 63.3 (14.2) 78.7 (17.8) 15.4 (1,67) .0002
CGAS Score / Time 2 72.6 (13.3) 86.3 (13.0) 17.1 (1, 67) .0001
SOPS Score / Time 2 8.8 (11.5) 2.6 (5.0) 6.5 (1, 66) .014
Note: ANOVA = analysis of variance; CGAS = Children’s Global Assessment Scale; SOPS = Syndrome Scale of Prodromal Symptoms; VCFS =
Velo-cardio-facial syndrome
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Table 2
Medications and Psychiatric Diagnoses Based on the Time 2 K-SADS-PL
VCFS
(N=44)
Controls
(N=25)
Frequency (%) Frequency (%)
Psychiatric Diagnoses
Major Depressive Disorder 6 (13.6) 0
Bipolar Disorder, NOS 1 (2.2) 0
Anxiety Disorder (includes Separation, Overanxious, Generalized) 4 (9) 0
Obsessive Compulsive Disorder 2 (4.5) 1 (4)
Simple or Social Phobia 5 (11.4) 1 (4)
Attention Deficit Hyperactivity Disorder 13 (29.5) 3 (12)
History of Subthreshold Psychotic Symptoms 11 (25) 1 (4)
Medication Classes
Total N Taking Psychotropic Medications 15 (34.1) 5 (20)
Stimulants / Straterra 10 (22.7) 4 (16)
Anti-depressants 4 (9) 1 (4)
Mood Stabilizers 4 (9) 0
Alpha 2 Agonists 1 (2.2) 0
Anti-psychotics 5 (11.4) 1 (4)
Other (Metyrosine) 1 (2.2) 0
Note: K-SADS-PL = Schedule for Affective Disorders and Schizophrenia for School-Age Children—Present and Lifetime Version; NOS = not
otherwise specified; VCFS = Velo-cardio-facial Syndrome
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